TCVAX Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for TCVAX (TCVAX) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| CRMMX CRM Mid Cap Value Inv | $23.32 +0.52% |
| PQNAX Virtus NFJ Mid Cap Value Fund Class A | $27.11 +0.82% |
| PRNIX Virtus NFJ Mid Cap Value Fund Institutional Class | $30.82 +0.82% |
| SSQSX State Street Institutional Small-Cap Equity Fund Service Class | $15.25 +0.79% |
| GMXAX Nationwide Mid Cap Market Index Fund Class A | $16.09 +0.31% |
| SEVIX SEI Institutional Managed Trust U.S. Managed Volatility Fund Class I | $14.75 -0.34% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| CRMMX CRM Mid Cap Value Inv | $23.32 | +0.52% | 561.03 M | 11.94 | 1.95 | 5.84% | — | 0 |
| PQNAX Virtus NFJ Mid Cap Value Fund Class A | $27.11 | +0.82% | 526.02 M | 18.12 | 1.50 | 5.65% | — | 0 |
| PRNIX Virtus NFJ Mid Cap Value Fund Institutional Class | $30.82 | +0.82% | 521.75 M | 18.13 | 1.70 | 5.14% | — | 0 |
| SSQSX State Street Institutional Small-Cap Equity Fund Service Class | $15.25 | +0.79% | 468.29 M | 21.95 | 0.69 | 16.75% | — | 0 |
| GMXAX Nationwide Mid Cap Market Index Fund Class A | $16.09 | +0.31% | 446.93 M | 22.01 | 0.73 | 12.19% | — | 0 |
| SEVIX SEI Institutional Managed Trust U.S. Managed Volatility Fund Class I | $14.75 | -0.34% | 518.88 M | 18.56 | 0.79 | 0.51% | — | 0 |
Frequently Asked Questions
What are TCVAX's latest financial results?
Review TCVAX's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has TCVAX's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is TCVAX's cash flow situation and liquidity?
Cash flow statements reveal how TCVAX generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does TCVAX's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether TCVAX is outperforming or lagging within its sector.
Are TCVAX's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether TCVAX's profits are repeatable and supported by strong fundamentals.